Personal tools

MCL coexpression mm9:75: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0354470656487682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116598907606497,0,0,0,0,0,0,0,0,0,0,0.0469568706916304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0421182837367051,0,0,0.00325666978963657,0,0,0,0.204884555489854,0,0,0,0,0,0,0,0,0.378440827859929,0.895872150453789,0.974837065681437,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.259908275861658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.866148947470017,0.995449255022101,0.847919379762534,0.903801467355784,0.856717364823651,0,0,0,0,0,0,0,0,0,0,0,0.682928309331839,0,0,0.188891057265938,0.677934313650774,0.748902920672635,0.777425431501973,0.617001005078464,0.756758313817433,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.2359854618948,0,0,0,0,0,0,1.17417453707349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.218189286835971,0,0.156277714692913,0.159715578577694,0.149856261570464,0.137031909345019,0.245041507634362,0.178101321237085,0.139013627015232,0.193639056320997,0.176645893644427,0.185522391978281,0.169172763866184,0.165403796547116,0.194873968017062,0.14986111676545,0.201068050435521,0.226790206858766,0.185379913858661,0.169342968499384,0.199037798091534,0.194418948264644,0.188895860025179,0.172825148572711,0.18359421108913,0.162361197470568,0.193442483447008,0.168656579551575,0.17392086126324,0.148982201447044,0.167368059764058,0.545033083349415,0.543832937991774,0.523657529338038,0.540248621101407,0.369033624199149,0.32283041232717,0.0302752311721997
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0354470656487682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116598907606497,0,0,0,0,0,0,0,0,0,0,0.0469568706916304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0421182837367051,0,0,0.00325666978963657,0,0,0,0.204884555489854,0,0,0,0,0,0,0,0,0.378440827859929,0.895872150453789,0.974837065681437,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.259908275861658,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.866148947470017,0.995449255022101,0.847919379762534,0.903801467355784,0.856717364823651,0,0,0,0,0,0,0,0,0,0,0,0.682928309331839,0,0,0.188891057265938,0.677934313650774,0.748902920672635,0.777425431501973,0.617001005078464,0.756758313817433,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.2359854618948,0,0,0,0,0,0,1.17417453707349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.218189286835971,0,0.156277714692913,0.159715578577694,0.149856261570464,0.137031909345019,0.245041507634362,0.178101321237085,0.139013627015232,0.193639056320997,0.176645893644427,0.185522391978281,0.169172763866184,0.165403796547116,0.194873968017062,0.14986111676545,0.201068050435521,0.226790206858766,0.185379913858661,0.169342968499384,0.199037798091534,0.194418948264644,0.188895860025179,0.172825148572711,0.18359421108913,0.162361197470568,0.193442483447008,0.168656579551575,0.17392086126324,0.148982201447044,0.167368059764058,0.545033083349415,0.543832937991774,0.523657529338038,0.540248621101407,0.369033624199149,0.32283041232717,0.0302752311721997
|gostat_on_MCL_coexpression=GO:0008544;epidermis development;4.37505799626704e-08;67855,14027,64929,16939,21816,12023,230824,110308,19041!GO:0007398;ectoderm development;4.37505799626704e-08;67855,14027,64929,16939,21816,12023,230824,110308,19041!GO:0009888;tissue development;1.96428993550715e-05;67855,666279,14027,64929,21816,16939,12023,230824,110308,19041!GO:0030057;desmosome;2.53581179068666e-05;386463,13510,225256,13505!GO:0008233;peptidase activity;0.000114933984441675;209232,16613,67855,71791,226418,72432,20725,75221,15925,70008,13648,18788,243083!GO:0016787;hydrolase activity;0.000114933984441675;271844,16613,67855,71791,226418,20725,75221,271457,70008,66198,18788,209232,433091,71884,72432,15925,240633,403178,24102,13648,243083!GO:0030054;cell junction;0.000143025842598808;13510,18772,14027,386463,64058,21816,12821,225256,13505,19041!GO:0031424;keratinization;0.000214087444236872;14027,21816,16939,19041!GO:0009913;epidermal cell differentiation;0.000554772196953506;14027,21816,16939,19041!GO:0014704;intercalated disc;0.00138032072496803;386463,13510,225256,13505!GO:0048730;epidermis morphogenesis;0.00176392650888208;14027,21816,16939,19041!GO:0048729;tissue morphogenesis;0.00808970761995868;14027,21816,16939,19041!GO:0003810;protein-glutamine gamma-glutamyltransferase activity;0.00808970761995868;74176,21816!GO:0018149;peptide cross-linking;0.00808970761995868;74176,21816!GO:0005911;intercellular junction;0.00930381502823334;386463,13510,21816,225256,13505!GO:0001726;ruffle;0.00930381502823334;271457,67425,14457!GO:0016165;lipoxygenase activity;0.00930381502823334;23801,11686!GO:0043296;apical junction complex;0.010602239102886;386463,13510,225256,13505!GO:0016327;apicolateral plasma membrane;0.0109428847960425;386463,13510,225256,13505!GO:0044459;plasma membrane part;0.0129403618494906;13510,18772,320718,14027,271457,64058,386463,21816,12821,16939,67516,225256,19041,13505!GO:0004867;serine-type endopeptidase inhibitor activity;0.0153275580725187;71869,72432,20725,18788!GO:0016755;transferase activity, transferring amino-acyl groups;0.0223162804335706;74176,21816!GO:0004293;tissue kallikrein activity;0.0251646083949542;16613,13648!GO:0019370;leukotriene biosynthetic process;0.035111495357553;23801,11686!GO:0043450;alkene biosynthetic process;0.035111495357553;23801,11686!GO:0022610;biological adhesion;0.035111495357553;13510,18772,72432,64058,12821,225256,72434,13505!GO:0007155;cell adhesion;0.035111495357553;13510,18772,72432,64058,12821,225256,72434,13505!GO:0006691;leukotriene metabolic process;0.0356860640717871;23801,11686!GO:0043449;alkene metabolic process;0.0376507214843083;23801,11686!GO:0006508;proteolysis;0.0376507214843083;16613,67855,71791,72432,75221,15925,13648,243083!GO:0004866;endopeptidase inhibitor activity;0.0376507214843083;71869,72432,20725,18788!GO:0030414;protease inhibitor activity;0.0393279550420495;71869,72432,20725,18788!GO:0005509;calcium ion binding;0.0455591662483469;74176,271844,13510,69543,21816,666279,225256,13505,70405!GO:0031252;leading edge;0.0480286345623551;271457,67425,14457!GO:0046456;icosanoid biosynthetic process;0.0480286345623551;23801,11686!GO:0051015;actin filament binding;0.0480286345623551;67425,14457!GO:0004231;insulysin activity;0.0480286345623551;15925!GO:0043758;acetate-CoA ligase (ADP-forming) activity;0.0480286345623551;14081!GO:0030280;structural constituent of epidermis;0.0480286345623551;16939!GO:0017039;dipeptidyl-peptidase III activity;0.0480286345623551;75221!
|gostat_on_MCL_coexpression=GO:0008544;epidermis development;4.37505799626704e-08;67855,14027,64929,16939,21816,12023,230824,110308,19041!GO:0007398;ectoderm development;4.37505799626704e-08;67855,14027,64929,16939,21816,12023,230824,110308,19041!GO:0009888;tissue development;1.96428993550715e-05;67855,666279,14027,64929,21816,16939,12023,230824,110308,19041!GO:0030057;desmosome;2.53581179068666e-05;386463,13510,225256,13505!GO:0008233;peptidase activity;0.000114933984441675;209232,16613,67855,71791,226418,72432,20725,75221,15925,70008,13648,18788,243083!GO:0016787;hydrolase activity;0.000114933984441675;271844,16613,67855,71791,226418,20725,75221,271457,70008,66198,18788,209232,433091,71884,72432,15925,240633,403178,24102,13648,243083!GO:0030054;cell junction;0.000143025842598808;13510,18772,14027,386463,64058,21816,12821,225256,13505,19041!GO:0031424;keratinization;0.000214087444236872;14027,21816,16939,19041!GO:0009913;epidermal cell differentiation;0.000554772196953506;14027,21816,16939,19041!GO:0014704;intercalated disc;0.00138032072496803;386463,13510,225256,13505!GO:0048730;epidermis morphogenesis;0.00176392650888208;14027,21816,16939,19041!GO:0048729;tissue morphogenesis;0.00808970761995868;14027,21816,16939,19041!GO:0003810;protein-glutamine gamma-glutamyltransferase activity;0.00808970761995868;74176,21816!GO:0018149;peptide cross-linking;0.00808970761995868;74176,21816!GO:0005911;intercellular junction;0.00930381502823334;386463,13510,21816,225256,13505!GO:0001726;ruffle;0.00930381502823334;271457,67425,14457!GO:0016165;lipoxygenase activity;0.00930381502823334;23801,11686!GO:0043296;apical junction complex;0.010602239102886;386463,13510,225256,13505!GO:0016327;apicolateral plasma membrane;0.0109428847960425;386463,13510,225256,13505!GO:0044459;plasma membrane part;0.0129403618494906;13510,18772,320718,14027,271457,64058,386463,21816,12821,16939,67516,225256,19041,13505!GO:0004867;serine-type endopeptidase inhibitor activity;0.0153275580725187;71869,72432,20725,18788!GO:0016755;transferase activity, transferring amino-acyl groups;0.0223162804335706;74176,21816!GO:0004293;tissue kallikrein activity;0.0251646083949542;16613,13648!GO:0019370;leukotriene biosynthetic process;0.035111495357553;23801,11686!GO:0043450;alkene biosynthetic process;0.035111495357553;23801,11686!GO:0022610;biological adhesion;0.035111495357553;13510,18772,72432,64058,12821,225256,72434,13505!GO:0007155;cell adhesion;0.035111495357553;13510,18772,72432,64058,12821,225256,72434,13505!GO:0006691;leukotriene metabolic process;0.0356860640717871;23801,11686!GO:0043449;alkene metabolic process;0.0376507214843083;23801,11686!GO:0006508;proteolysis;0.0376507214843083;16613,67855,71791,72432,75221,15925,13648,243083!GO:0004866;endopeptidase inhibitor activity;0.0376507214843083;71869,72432,20725,18788!GO:0030414;protease inhibitor activity;0.0393279550420495;71869,72432,20725,18788!GO:0005509;calcium ion binding;0.0455591662483469;74176,271844,13510,69543,21816,666279,225256,13505,70405!GO:0031252;leading edge;0.0480286345623551;271457,67425,14457!GO:0046456;icosanoid biosynthetic process;0.0480286345623551;23801,11686!GO:0051015;actin filament binding;0.0480286345623551;67425,14457!GO:0004231;insulysin activity;0.0480286345623551;15925!GO:0043758;acetate-CoA ligase (ADP-forming) activity;0.0480286345623551;14081!GO:0030280;structural constituent of epidermis;0.0480286345623551;16939!GO:0017039;dipeptidyl-peptidase III activity;0.0480286345623551;75221!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000014!1.25e-09!5;UBERON:0001003!1.25e-09!5;UBERON:0002097!1.25e-09!5;UBERON:0002199!1.25e-09!5;UBERON:0007029!1.25e-09!5;UBERON:0007376!1.25e-09!5;UBERON:0002416!1.25e-09!5;UBERON:0007383!1.25e-09!5
}}
}}

Revision as of 21:11, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:127335594..127335605,+p3@Sdr9c7
Mm9::chr10:127335606..127335611,+p6@Sdr9c7
Mm9::chr10:18265577..18265584,-p@chr10:18265577..18265584
-
Mm9::chr10:18265599..18265612,-p4@Hebp2
Mm9::chr10:18265686..18265737,-p1@Hebp2
Mm9::chr10:18265822..18265836,-p3@Hebp2
Mm9::chr10:18564930..18564945,+p1@Perp
Mm9::chr10:43868593..43868610,-p@chr10:43868593..43868610
-
Mm9::chr10:6511612..6511629,-p@chr10:6511612..6511629
-
Mm9::chr11:116099397..116099411,-p1@Evpl
Mm9::chr11:20731176..20731192,-p2@1110067D22Rik
Mm9::chr11:46036104..46036128,+p@chr11:46036104..46036128
+
Mm9::chr11:67346577..67346593,+p8@Gas7
Mm9::chr11:68939606..68939618,+p4@Aloxe3
Mm9::chr11:68939688..68939712,+p2@Aloxe3
Mm9::chr11:68939720..68939751,+p1@Aloxe3
Mm9::chr11:68970390..68970403,+p4@Alox12b
Mm9::chr11:68970415..68970418,+p7@Alox12b
Mm9::chr11:68970534..68970553,+p1@Alox12b
Mm9::chr11:68970555..68970563,+p5@Alox12b
Mm9::chr11:68970565..68970583,+p2@Alox12b
Mm9::chr11:68970586..68970612,+p3@Alox12b
Mm9::chr11:70354393..70354409,+p@chr11:70354393..70354409
+
Mm9::chr11:70354413..70354420,+p@chr11:70354413..70354420
+
Mm9::chr12:113368990..113368996,+p1@Mir203
Mm9::chr12:72990525..72990543,+p4@Daam1
Mm9::chr13:3802531..3802537,-p@chr13:3802531..3802537
-
Mm9::chr13:3803460..3803485,-p2@Calml3
Mm9::chr13:38243240..38243262,+p1@Dsp
Mm9::chr14:103912595..103912646,+p2@Scel
Mm9::chr14:21427093..21427122,-p@chr14:21427093..21427122
-
Mm9::chr14:35168569..35168587,-p1@Fam25c
Mm9::chr14:56332319..56332340,-p1@Tgm1
Mm9::chr14:70946282..70946293,+p@chr14:70946282..70946293
+
Mm9::chr14:76354818..76354823,+p2@Kctd4
Mm9::chr14:76354857..76354870,+p1@Kctd4
Mm9::chr15:101179878..101179883,-p@chr15:101179878..101179883
-
Mm9::chr15:101537980..101537994,-p@chr15:101537980..101537994
-
Mm9::chr15:101538012..101538024,-p@chr15:101538012..101538024
-
Mm9::chr15:101540044..101540058,-p@chr15:101540044..101540058
-
Mm9::chr15:101540268..101540287,-p@chr15:101540268..101540287
-
Mm9::chr15:101784680..101784696,-p2@Krt78
p2@LOC100505154
Mm9::chr15:63640288..63640300,-p1@Gsdmc
Mm9::chr15:74577218..74577227,-p3@2300005B03Rik
Mm9::chr16:25286896..25286912,+p1@Tprg
Mm9::chr16:25286934..25286960,+p2@Tprg
Mm9::chr16:5132551..5132576,-p1@Ppl
Mm9::chr16:56867774..56867783,-p@chr16:56867774..56867783
-
Mm9::chr17:28995510..28995518,+p3@Pnpla1
Mm9::chr17:32326384..32326395,-p2@Ephx3
Mm9::chr17:32326402..32326421,-p1@Ephx3
Mm9::chr17:32589664..32589676,+p2@Cyp4f39
Mm9::chr17:32589690..32589702,+p1@Cyp4f39
Mm9::chr17:35205804..35205830,+p@chr17:35205804..35205830
+
Mm9::chr17:35206317..35206331,+p@chr17:35206317..35206331
+
Mm9::chr17:35689112..35689127,+p1@Cdsn
Mm9::chr17:35693265..35693300,+p@chr17:35693265..35693300
+
Mm9::chr17:53618852..53618863,+p7@Rab5a
Mm9::chr17:72130582..72130593,+p4@Clip4
Mm9::chr17:72130615..72130624,+p3@Clip4
Mm9::chr17:72130627..72130646,+p2@Clip4
Mm9::chr18:20273140..20273172,-p2@Dsc1
Mm9::chr18:20273174..20273190,-p3@Dsc1
Mm9::chr18:20273203..20273214,-p6@Dsc1
Mm9::chr18:20273268..20273283,-p4@Dsc1
Mm9::chr18:20273294..20273314,-p1@Dsc1
Mm9::chr18:20273355..20273366,-p5@Dsc1
Mm9::chr18:20273375..20273384,-p7@Dsc1
Mm9::chr18:20469424..20469430,+p1@Dsg1a
Mm9::chr18:20535340..20535347,+p1@Dsg1b
Mm9::chr18:44122888..44122906,+p1@Spink5
Mm9::chr19:10799791..10799801,-p@chr19:10799791..10799801
-
Mm9::chr19:34082774..34082785,+p3@Lipk
Mm9::chr19:37412335..37412343,-p1@Ide
Mm9::chr19:47490678..47490692,-p@chr19:47490678..47490692
-
Mm9::chr19:47766338..47766365,-p3@Col17a1
Mm9::chr19:47766374..47766394,-p4@Col17a1
Mm9::chr19:47766399..47766402,-p7@Col17a1
Mm9::chr19:4927313..4927326,-p@chr19:4927313..4927326
-
Mm9::chr1:108831057..108831071,+p4@Serpinb12
Mm9::chr1:108835530..108835535,+p2@Serpinb12
Mm9::chr1:109059807..109059816,-p@chr1:109059807..109059816
-
Mm9::chr1:109408040..109408045,+p5@Serpinb2
Mm9::chr1:109408066..109408079,+p2@Serpinb2
Mm9::chr1:109486635..109486690,+p2@Serpinb8
Mm9::chr1:132613897..132613910,+p1@Yod1
Mm9::chr1:133646958..133646963,+p4@Slc26a9
Mm9::chr1:136007810..136007825,+p1@Chit1
Mm9::chr1:137715302..137715316,+p5@Lad1
Mm9::chr1:137815701..137815712,-p5@Pkp1
Mm9::chr1:137815741..137815752,-p3@Pkp1
Mm9::chr1:137815776..137815789,-p1@Pkp1
Mm9::chr1:137815871..137815884,-p4@Pkp1
Mm9::chr1:137815898..137815916,-p2@Pkp1
Mm9::chr1:137815919..137815930,-p6@Pkp1
Mm9::chr1:137815931..137815936,-p7@Pkp1
Mm9::chr1:166237312..166237323,-p4@Blzf1
Mm9::chr1:40382431..40382454,+p@chr1:40382431..40382454
+
Mm9::chr2:119859189..119859202,+p2@Jmjd7
p2@Pla2g4b
Mm9::chr2:120139817..120139842,-p2@Pla2g4f
Mm9::chr2:120139851..120139872,-p3@Pla2g4f
Mm9::chr2:120911482..120911489,-p4@Tgm5
Mm9::chr2:120911514..120911530,-p1@Tgm5
Mm9::chr2:157822882..157822915,-p@chr2:157822882..157822915
-
Mm9::chr2:164008465..164008502,-p1@Wfdc5
Mm9::chr2:24008668..24008685,+p2@Il1f8
Mm9::chr2:25095370..25095390,-p1@2310002J15Rik
Mm9::chr2:25097423..25097446,+p3@Rnf208
Mm9::chr3:14644912..14644941,+p@chr3:14644912..14644941
+
Mm9::chr3:58998953..58998976,-p2@Gpr87
Mm9::chr3:59810784..59810801,+p1@Aadacl2
Mm9::chr3:91884223..91884269,-p@chr3:91884223..91884269
-
Mm9::chr3:91884835..91884853,-p@chr3:91884835..91884853
-
Mm9::chr3:91885275..91885288,-p@chr3:91885275..91885288
-
Mm9::chr3:91887054..91887069,-p1@Lor
Mm9::chr3:91917108..91917121,+p@chr3:91917108..91917121
+
Mm9::chr3:92451302..92451307,-p@chr3:92451302..92451307
-
Mm9::chr3:92628957..92628968,-p@chr3:92628957..92628968
-
Mm9::chr3:92631161..92631179,-p1@Kprp
Mm9::chr3:92819601..92819616,-p1@Crct1
Mm9::chr3:94146014..94146034,+p1@Them5
Mm9::chr4:123797763..123797785,-p@chr4:123797763..123797785
-
Mm9::chr4:132807268..132807303,+p@chr4:132807268..132807303
+
Mm9::chr4:132807325..132807336,+p@chr4:132807325..132807336
+
Mm9::chr4:135129447..135129467,-p2@Grhl3
Mm9::chr4:135129538..135129558,-p1@Grhl3
Mm9::chr4:139130612..139130640,+p2@Iffo2
Mm9::chr4:148913973..148913987,+p@chr4:148913973..148913987
+
Mm9::chr4:155602613..155602647,-p1@Plekhn1
Mm9::chr4:41083125..41083136,+p@chr4:41083125..41083136
+
Mm9::chr5:110529433..110529444,+p1@Plcxd1
Mm9::chr5:137432569..137432579,-p@chr5:137432569..137432579
-
Mm9::chr5:144374290..144374303,-p@chr5:144374290..144374303
-
Mm9::chr5:149363786..149363797,-p@chr5:149363786..149363797
-
Mm9::chr5:149363827..149363849,-p@chr5:149363827..149363849
-
Mm9::chr5:87061403..87061416,-p1@Tmprss11f
Mm9::chr6:116308974..116308991,+p@chr6:116308974..116308991
+
Mm9::chr6:30518367..30518382,+p1@Cpa4
Mm9::chr6:86578219..86578235,+p@chr6:86578219..86578235
+
Mm9::chr7:134705244..134705256,+p2@uc009jvz.1
Mm9::chr7:13512736..13512751,+p2@2310014L17Rik
Mm9::chr7:13512759..13512788,+p1@2310014L17Rik
Mm9::chr7:16870775..16870789,-p4@Ccdc9
Mm9::chr7:16870803..16870828,-p3@Ccdc9
Mm9::chr7:20102969..20102980,+p@chr7:20102969..20102980
+
Mm9::chr7:20103243..20103265,+p@chr7:20103243..20103265
+
Mm9::chr7:25134229..25134246,+p2@Lypd5
Mm9::chr7:25421563..25421583,+p1@Lypd3
Mm9::chr7:25421585..25421608,+p2@Lypd3
Mm9::chr7:26153100..26153115,-p@chr7:26153100..26153115
-
Mm9::chr7:26154067..26154134,-p@chr7:26154067..26154134
-
Mm9::chr7:29414713..29414732,-p@chr7:29414713..29414732
-
Mm9::chr7:29414741..29414760,-p@chr7:29414741..29414760
-
Mm9::chr7:29414771..29414782,-p@chr7:29414771..29414782
-
Mm9::chr7:29414811..29414821,-p@chr7:29414811..29414821
-
Mm9::chr7:4416931..4416977,+p3@Eps8l1
Mm9::chr7:51029978..51029992,+p1@Klk11
Mm9::chr7:51029994..51030006,+p3@Klk11
Mm9::chr7:51030012..51030018,+p5@Klk11
Mm9::chr7:51030022..51030034,+p4@Klk11
Mm9::chr7:51031636..51031668,+p2@Klk11
Mm9::chr7:51047321..51047352,+p1@Klk9
Mm9::chr7:51049513..51049525,+p@chr7:51049513..51049525
+
Mm9::chr7:73888573..73888592,+p@chr7:73888573..73888592
+
Mm9::chr7:99329188..99329244,+p3@Dlg2
Mm9::chr8:107485687..107485698,+p@chr8:107485687..107485698
+
Mm9::chr8:129695291..129695307,+p@chr8:129695291..129695307
+
Mm9::chr8:47576273..47576284,+p10@Acsl1
Mm9::chr8:71551549..71551592,-p@chr8:71551549..71551592
-
Mm9::chr8:95425337..95425346,+p5@Capns2
Mm9::chr8:95425347..95425365,+p2@Capns2
Mm9::chr9:107191722..107191753,-p2@Mapkapk3
Mm9::chr9:31720746..31720762,-p4@Barx2
Mm9::chr9:31923591..31923617,+p5@Arhgap32
Mm9::chr9:98386486..98386525,+p@chr9:98386486..98386525
+
Mm9::chrX:160577253..160577269,+p6@Ace2
Mm9::chrX:160577282..160577301,+p5@Ace2
Mm9::chrX:70680671..70680689,-p1@Trex2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0008544epidermis development4.37505799626704e-08
GO:0007398ectoderm development4.37505799626704e-08
GO:0009888tissue development1.96428993550715e-05
GO:0030057desmosome2.53581179068666e-05
GO:0008233peptidase activity0.000114933984441675
GO:0016787hydrolase activity0.000114933984441675
GO:0030054cell junction0.000143025842598808
GO:0031424keratinization0.000214087444236872
GO:0009913epidermal cell differentiation0.000554772196953506
GO:0014704intercalated disc0.00138032072496803
GO:0048730epidermis morphogenesis0.00176392650888208
GO:0048729tissue morphogenesis0.00808970761995868
GO:0003810protein-glutamine gamma-glutamyltransferase activity0.00808970761995868
GO:0018149peptide cross-linking0.00808970761995868
GO:0005911intercellular junction0.00930381502823334
GO:0001726ruffle0.00930381502823334
GO:0016165lipoxygenase activity0.00930381502823334
GO:0043296apical junction complex0.010602239102886
GO:0016327apicolateral plasma membrane0.0109428847960425
GO:0044459plasma membrane part0.0129403618494906
GO:0004867serine-type endopeptidase inhibitor activity0.0153275580725187
GO:0016755transferase activity, transferring amino-acyl groups0.0223162804335706
GO:0004293tissue kallikrein activity0.0251646083949542
GO:0019370leukotriene biosynthetic process0.035111495357553
GO:0043450alkene biosynthetic process0.035111495357553
GO:0022610biological adhesion0.035111495357553
GO:0007155cell adhesion0.035111495357553
GO:0006691leukotriene metabolic process0.0356860640717871
GO:0043449alkene metabolic process0.0376507214843083
GO:0006508proteolysis0.0376507214843083
GO:0004866endopeptidase inhibitor activity0.0376507214843083
GO:0030414protease inhibitor activity0.0393279550420495
GO:0005509calcium ion binding0.0455591662483469
GO:0031252leading edge0.0480286345623551
GO:0046456icosanoid biosynthetic process0.0480286345623551
GO:0051015actin filament binding0.0480286345623551
GO:0004231insulysin activity0.0480286345623551
GO:0043758acetate-CoA ligase (ADP-forming) activity0.0480286345623551
GO:0030280structural constituent of epidermis0.0480286345623551
GO:0017039dipeptidyl-peptidase III activity0.0480286345623551



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
zone of skin1.25e-095
skin epidermis1.25e-095
skin of body1.25e-095
integument1.25e-095
surface1.25e-095
outer epithelium1.25e-095
integumental system1.25e-095
enveloping layer of ectoderm1.25e-095


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:75&oldid=2156557"